nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Epirubicin—uterine cancer	0.135	0.519	CrCtD
Daunorubicin—Doxorubicin—uterine cancer	0.125	0.48	CrCtD
Daunorubicin—Anthracyclines—Epirubicin—uterine cancer	0.0905	0.271	CiPCiCtD
Daunorubicin—Anthracyclines—Doxorubicin—uterine cancer	0.0837	0.251	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Etoposide—uterine cancer	0.0687	0.206	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Epirubicin—uterine cancer	0.0473	0.142	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Doxorubicin—uterine cancer	0.0438	0.131	CiPCiCtD
Daunorubicin—Idarubicin—Epirubicin—uterine cancer	0.029	0.173	CrCrCtD
Daunorubicin—Valrubicin—Epirubicin—uterine cancer	0.029	0.173	CrCrCtD
Daunorubicin—Doxorubicin—Epirubicin—uterine cancer	0.029	0.173	CrCrCtD
Daunorubicin—Idarubicin—Doxorubicin—uterine cancer	0.0268	0.16	CrCrCtD
Daunorubicin—Valrubicin—Doxorubicin—uterine cancer	0.0268	0.16	CrCrCtD
Daunorubicin—Epirubicin—Doxorubicin—uterine cancer	0.0268	0.16	CrCrCtD
Daunorubicin—YWHAG—Epirubicin—uterine cancer	0.024	0.138	CbGbCtD
Daunorubicin—TOP2B—Etoposide—uterine cancer	0.0187	0.108	CbGbCtD
Daunorubicin—YWHAG—Doxorubicin—uterine cancer	0.0127	0.0734	CbGbCtD
Daunorubicin—ABCC6—Dactinomycin—uterine cancer	0.0126	0.0727	CbGbCtD
Daunorubicin—ABCC6—Etoposide—uterine cancer	0.00713	0.041	CbGbCtD
Daunorubicin—ABCB11—Progesterone—uterine cancer	0.00662	0.0381	CbGbCtD
Daunorubicin—CYP1B1—Progesterone—uterine cancer	0.00662	0.0381	CbGbCtD
Daunorubicin—ABCC10—Etoposide—uterine cancer	0.00545	0.0314	CbGbCtD
Daunorubicin—XDH—Carboplatin—uterine cancer	0.00531	0.0306	CbGbCtD
Daunorubicin—POR—Doxorubicin—uterine cancer	0.00529	0.0305	CbGbCtD
Daunorubicin—TOP2A—Epirubicin—uterine cancer	0.00487	0.028	CbGbCtD
Daunorubicin—ABCC6—Doxorubicin—uterine cancer	0.00486	0.028	CbGbCtD
Daunorubicin—ABCC1—Progesterone—uterine cancer	0.0047	0.0271	CbGbCtD
Daunorubicin—SLC22A2—Progesterone—uterine cancer	0.00426	0.0245	CbGbCtD
Daunorubicin—TOP2A—Etoposide—uterine cancer	0.0038	0.0218	CbGbCtD
Daunorubicin—ABCC1—Dactinomycin—uterine cancer	0.00373	0.0215	CbGbCtD
Daunorubicin—NR5A1—corpus luteum—uterine cancer	0.00372	0.225	CbGeAlD
Daunorubicin—ABCC10—Doxorubicin—uterine cancer	0.00372	0.0214	CbGbCtD
Daunorubicin—XDH—Doxorubicin—uterine cancer	0.00304	0.0175	CbGbCtD
Daunorubicin—CYP1A1—Progesterone—uterine cancer	0.0029	0.0167	CbGbCtD
Daunorubicin—ABCC1—Epirubicin—uterine cancer	0.0027	0.0155	CbGbCtD
Daunorubicin—TOP2A—Doxorubicin—uterine cancer	0.00259	0.0149	CbGbCtD
Daunorubicin—ABCG2—Dactinomycin—uterine cancer	0.00249	0.0144	CbGbCtD
Daunorubicin—ABCC1—Etoposide—uterine cancer	0.0021	0.0121	CbGbCtD
Daunorubicin—ABCB11—Doxorubicin—uterine cancer	0.00202	0.0116	CbGbCtD
Daunorubicin—CYP1B1—Doxorubicin—uterine cancer	0.00202	0.0116	CbGbCtD
Daunorubicin—ABCC2—Carboplatin—uterine cancer	0.00185	0.0107	CbGbCtD
Daunorubicin—CYP3A5—Progesterone—uterine cancer	0.00174	0.01	CbGbCtD
Daunorubicin—ABCG2—Carboplatin—uterine cancer	0.00168	0.00965	CbGbCtD
Daunorubicin—ABCC2—Etoposide—uterine cancer	0.00156	0.00896	CbGbCtD
Daunorubicin—ABCC1—Doxorubicin—uterine cancer	0.00143	0.00826	CbGbCtD
Daunorubicin—ABCG2—Etoposide—uterine cancer	0.00141	0.0081	CbGbCtD
Daunorubicin—CYP1A2—Progesterone—uterine cancer	0.0013	0.00747	CbGbCtD
Daunorubicin—ABCB1—Progesterone—uterine cancer	0.00113	0.00653	CbGbCtD
Daunorubicin—ABCC2—Doxorubicin—uterine cancer	0.00106	0.00611	CbGbCtD
Daunorubicin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00591	CbGbCtD
Daunorubicin—ABCG2—Doxorubicin—uterine cancer	0.00096	0.00553	CbGbCtD
Daunorubicin—ABCB1—Dactinomycin—uterine cancer	0.0009	0.00518	CbGbCtD
Daunorubicin—CYP3A5—Etoposide—uterine cancer	0.00078	0.00449	CbGbCtD
Daunorubicin—CYP3A4—Progesterone—uterine cancer	0.00068	0.00391	CbGbCtD
Daunorubicin—CYP1A2—Etoposide—uterine cancer	0.000581	0.00334	CbGbCtD
Daunorubicin—ABCB1—Etoposide—uterine cancer	0.000508	0.00292	CbGbCtD
Daunorubicin—Doxorubicin—AKR1C3—uterine cancer	0.000428	1	CrCbGaD
Daunorubicin—ABCB1—Doxorubicin—uterine cancer	0.000346	0.00199	CbGbCtD
Daunorubicin—CYP3A4—Etoposide—uterine cancer	0.000304	0.00175	CbGbCtD
Daunorubicin—YWHAG—myometrium—uterine cancer	0.00027	0.0163	CbGeAlD
Daunorubicin—TOP2B—myometrium—uterine cancer	0.00026	0.0157	CbGeAlD
Daunorubicin—TOP2B—Teniposide—Etoposide—uterine cancer	0.000245	0.343	CbGdCrCtD
Daunorubicin—NR5A1—female reproductive system—uterine cancer	0.000238	0.0144	CbGeAlD
Daunorubicin—ABCC6—Podofilox—Etoposide—uterine cancer	0.000218	0.305	CbGdCrCtD
Daunorubicin—NR5A1—female gonad—uterine cancer	0.000217	0.0131	CbGeAlD
Daunorubicin—YWHAG—uterine cervix—uterine cancer	0.00021	0.0127	CbGeAlD
Daunorubicin—ABCC6—renal system—uterine cancer	0.000209	0.0126	CbGeAlD
Daunorubicin—CYP3A4—Doxorubicin—uterine cancer	0.000207	0.00119	CbGbCtD
Daunorubicin—POR—myometrium—uterine cancer	0.000205	0.0124	CbGeAlD
Daunorubicin—XDH—uterine cervix—uterine cancer	0.000205	0.0124	CbGeAlD
Daunorubicin—YWHAG—smooth muscle tissue—uterine cancer	0.000204	0.0124	CbGeAlD
Daunorubicin—TOP2B—uterine cervix—uterine cancer	0.000203	0.0122	CbGeAlD
Daunorubicin—YWHAG—decidua—uterine cancer	0.0002	0.0121	CbGeAlD
Daunorubicin—TOP2B—smooth muscle tissue—uterine cancer	0.000197	0.0119	CbGeAlD
Daunorubicin—YWHAG—renal system—uterine cancer	0.000197	0.0119	CbGeAlD
Daunorubicin—TOP2B—decidua—uterine cancer	0.000193	0.0117	CbGeAlD
Daunorubicin—XDH—renal system—uterine cancer	0.000192	0.0116	CbGeAlD
Daunorubicin—TOP2A—myometrium—uterine cancer	0.000191	0.0116	CbGeAlD
Daunorubicin—YWHAG—endometrium—uterine cancer	0.00019	0.0115	CbGeAlD
Daunorubicin—TOP2B—renal system—uterine cancer	0.00019	0.0115	CbGeAlD
Daunorubicin—XDH—endometrium—uterine cancer	0.000185	0.0112	CbGeAlD
Daunorubicin—YWHAG—mammalian vulva—uterine cancer	0.000184	0.0111	CbGeAlD
Daunorubicin—TOP2B—endometrium—uterine cancer	0.000183	0.0111	CbGeAlD
Daunorubicin—XDH—mammalian vulva—uterine cancer	0.000179	0.0108	CbGeAlD
Daunorubicin—TOP2B—mammalian vulva—uterine cancer	0.000177	0.0107	CbGeAlD
Daunorubicin—YWHAG—uterus—uterine cancer	0.000175	0.0106	CbGeAlD
Daunorubicin—TOP2B—uterus—uterine cancer	0.000169	0.0102	CbGeAlD
Daunorubicin—ABCC10—myometrium—uterine cancer	0.000163	0.00985	CbGeAlD
Daunorubicin—POR—uterine cervix—uterine cancer	0.00016	0.00966	CbGeAlD
Daunorubicin—YWHAG—female reproductive system—uterine cancer	0.000158	0.00952	CbGeAlD
Daunorubicin—XDH—female reproductive system—uterine cancer	0.000154	0.00929	CbGeAlD
Daunorubicin—POR—decidua—uterine cancer	0.000152	0.00921	CbGeAlD
Daunorubicin—TOP2B—female reproductive system—uterine cancer	0.000152	0.00918	CbGeAlD
Daunorubicin—SLC22A2—renal system—uterine cancer	0.00015	0.00909	CbGeAlD
Daunorubicin—TOP2A—uterine cervix—uterine cancer	0.000149	0.00901	CbGeAlD
Daunorubicin—POR—endometrium—uterine cancer	0.000145	0.00874	CbGeAlD
Daunorubicin—YWHAG—female gonad—uterine cancer	0.000143	0.00867	CbGeAlD
Daunorubicin—YWHAG—vagina—uterine cancer	0.000142	0.00861	CbGeAlD
Daunorubicin—TOP2A—decidua—uterine cancer	0.000142	0.00858	CbGeAlD
Daunorubicin—POR—mammalian vulva—uterine cancer	0.00014	0.00846	CbGeAlD
Daunorubicin—XDH—vagina—uterine cancer	0.000139	0.0084	CbGeAlD
Daunorubicin—TOP2B—female gonad—uterine cancer	0.000138	0.00835	CbGeAlD
Daunorubicin—TOP2B—vagina—uterine cancer	0.000137	0.0083	CbGeAlD
Daunorubicin—TOP2A—endometrium—uterine cancer	0.000135	0.00815	CbGeAlD
Daunorubicin—TOP2A—mammalian vulva—uterine cancer	0.00013	0.00788	CbGeAlD
Daunorubicin—ABCC10—uterine cervix—uterine cancer	0.000127	0.00767	CbGeAlD
Daunorubicin—TOP2A—uterus—uterine cancer	0.000124	0.00751	CbGeAlD
Daunorubicin—ABCC10—decidua—uterine cancer	0.000121	0.00731	CbGeAlD
Daunorubicin—ABCC10—renal system—uterine cancer	0.000119	0.00717	CbGeAlD
Daunorubicin—ABCC1—myometrium—uterine cancer	0.000115	0.00697	CbGeAlD
Daunorubicin—ABCC10—endometrium—uterine cancer	0.000115	0.00694	CbGeAlD
Daunorubicin—ABCC10—mammalian vulva—uterine cancer	0.000111	0.00671	CbGeAlD
Daunorubicin—POR—female gonad—uterine cancer	0.000109	0.00659	CbGeAlD
Daunorubicin—POR—vagina—uterine cancer	0.000108	0.00655	CbGeAlD
Daunorubicin—ABCC10—uterus—uterine cancer	0.000106	0.00639	CbGeAlD
Daunorubicin—TOP2A—female gonad—uterine cancer	0.000102	0.00614	CbGeAlD
Daunorubicin—TOP2A—vagina—uterine cancer	0.000101	0.0061	CbGeAlD
Daunorubicin—CYP1B1—smooth muscle tissue—uterine cancer	9.69e-05	0.00586	CbGeAlD
Daunorubicin—ABCG2—myometrium—uterine cancer	9.54e-05	0.00577	CbGeAlD
Daunorubicin—ABCC2—renal system—uterine cancer	9.53e-05	0.00576	CbGeAlD
Daunorubicin—ABCC10—female reproductive system—uterine cancer	9.5e-05	0.00575	CbGeAlD
Daunorubicin—CYP1B1—decidua—uterine cancer	9.5e-05	0.00574	CbGeAlD
Daunorubicin—CYP1B1—renal system—uterine cancer	9.33e-05	0.00564	CbGeAlD
Daunorubicin—YWHAG—lymph node—uterine cancer	9.21e-05	0.00557	CbGeAlD
Daunorubicin—ABCC1—uterine cervix—uterine cancer	8.97e-05	0.00542	CbGeAlD
Daunorubicin—TOP2B—lymph node—uterine cancer	8.88e-05	0.00537	CbGeAlD
Daunorubicin—ABCC10—female gonad—uterine cancer	8.65e-05	0.00523	CbGeAlD
Daunorubicin—ABCC10—vagina—uterine cancer	8.59e-05	0.0052	CbGeAlD
Daunorubicin—ABCC1—decidua—uterine cancer	8.55e-05	0.00517	CbGeAlD
Daunorubicin—CYP1B1—uterus—uterine cancer	8.31e-05	0.00503	CbGeAlD
Daunorubicin—ABCC1—endometrium—uterine cancer	8.11e-05	0.00491	CbGeAlD
Daunorubicin—ABCC1—mammalian vulva—uterine cancer	7.85e-05	0.00474	CbGeAlD
Daunorubicin—ABCC2—female reproductive system—uterine cancer	7.63e-05	0.00461	CbGeAlD
Daunorubicin—ABCC1—uterus—uterine cancer	7.48e-05	0.00452	CbGeAlD
Daunorubicin—CYP1B1—female reproductive system—uterine cancer	7.47e-05	0.00452	CbGeAlD
Daunorubicin—ABCG2—uterine cervix—uterine cancer	7.43e-05	0.00449	CbGeAlD
Daunorubicin—CYP1A1—epithelium—uterine cancer	7.11e-05	0.0043	CbGeAlD
Daunorubicin—ABCG2—decidua—uterine cancer	7.08e-05	0.00428	CbGeAlD
Daunorubicin—CYP1A1—uterine cervix—uterine cancer	7.05e-05	0.00426	CbGeAlD
Daunorubicin—POR—lymph node—uterine cancer	7.01e-05	0.00424	CbGeAlD
Daunorubicin—CYP3A5—uterine cervix—uterine cancer	6.89e-05	0.00417	CbGeAlD
Daunorubicin—CYP1B1—female gonad—uterine cancer	6.8e-05	0.00411	CbGeAlD
Daunorubicin—ABCG2—endometrium—uterine cancer	6.72e-05	0.00406	CbGeAlD
Daunorubicin—CYP1A2—renal system—uterine cancer	6.69e-05	0.00404	CbGeAlD
Daunorubicin—CYP1A1—renal system—uterine cancer	6.6e-05	0.00399	CbGeAlD
Daunorubicin—TOP2A—lymph node—uterine cancer	6.53e-05	0.00395	CbGeAlD
Daunorubicin—ABCG2—mammalian vulva—uterine cancer	6.5e-05	0.00393	CbGeAlD
Daunorubicin—CYP3A5—renal system—uterine cancer	6.45e-05	0.0039	CbGeAlD
Daunorubicin—ABCG2—uterus—uterine cancer	6.19e-05	0.00374	CbGeAlD
Daunorubicin—CYP1A1—mammalian vulva—uterine cancer	6.17e-05	0.00373	CbGeAlD
Daunorubicin—ABCC1—female gonad—uterine cancer	6.12e-05	0.0037	CbGeAlD
Daunorubicin—ABCC1—vagina—uterine cancer	6.08e-05	0.00368	CbGeAlD
Daunorubicin—CYP1A1—uterus—uterine cancer	5.88e-05	0.00355	CbGeAlD
Daunorubicin—ABCC10—lymph node—uterine cancer	5.56e-05	0.00336	CbGeAlD
Daunorubicin—CYP1A1—female reproductive system—uterine cancer	5.28e-05	0.00319	CbGeAlD
Daunorubicin—ABCG2—female gonad—uterine cancer	5.06e-05	0.00306	CbGeAlD
Daunorubicin—ABCG2—vagina—uterine cancer	5.03e-05	0.00304	CbGeAlD
Daunorubicin—CYP3A4—renal system—uterine cancer	4.84e-05	0.00293	CbGeAlD
Daunorubicin—CYP1A1—female gonad—uterine cancer	4.81e-05	0.00291	CbGeAlD
Daunorubicin—CYP1A1—vagina—uterine cancer	4.78e-05	0.00289	CbGeAlD
Daunorubicin—ABCB1—myometrium—uterine cancer	4.71e-05	0.00285	CbGeAlD
Daunorubicin—CYP3A5—female gonad—uterine cancer	4.7e-05	0.00284	CbGeAlD
Daunorubicin—CYP3A5—vagina—uterine cancer	4.67e-05	0.00282	CbGeAlD
Daunorubicin—ABCC2—lymph node—uterine cancer	4.46e-05	0.0027	CbGeAlD
Daunorubicin—CYP1B1—lymph node—uterine cancer	4.37e-05	0.00264	CbGeAlD
Daunorubicin—TOP2A—Podofilox—Etoposide—uterine cancer	3.96e-05	0.0553	CbGdCrCtD
Daunorubicin—TOP2A—Teniposide—Etoposide—uterine cancer	3.96e-05	0.0553	CbGdCrCtD
Daunorubicin—ABCC1—lymph node—uterine cancer	3.93e-05	0.00238	CbGeAlD
Daunorubicin—CYP3A4—female reproductive system—uterine cancer	3.88e-05	0.00234	CbGeAlD
Daunorubicin—ABCB1—epithelium—uterine cancer	3.69e-05	0.00223	CbGeAlD
Daunorubicin—ABCB1—uterine cervix—uterine cancer	3.66e-05	0.00221	CbGeAlD
Daunorubicin—ABCB1—decidua—uterine cancer	3.49e-05	0.00211	CbGeAlD
Daunorubicin—ABCB1—renal system—uterine cancer	3.43e-05	0.00207	CbGeAlD
Daunorubicin—ABCB1—endometrium—uterine cancer	3.31e-05	0.002	CbGeAlD
Daunorubicin—ABCG2—lymph node—uterine cancer	3.26e-05	0.00197	CbGeAlD
Daunorubicin—TOP2A—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	3.23e-05	0.0451	CbGdCrCtD
Daunorubicin—ABCB1—mammalian vulva—uterine cancer	3.2e-05	0.00194	CbGeAlD
Daunorubicin—CYP1A1—lymph node—uterine cancer	3.09e-05	0.00187	CbGeAlD
Daunorubicin—Hepatic function abnormal—Epirubicin—uterine cancer	3.05e-05	0.00101	CcSEcCtD
Daunorubicin—ABCB1—uterus—uterine cancer	3.05e-05	0.00185	CbGeAlD
Daunorubicin—Dizziness—Progesterone—uterine cancer	3.02e-05	0.000999	CcSEcCtD
Daunorubicin—Hypertonia—Doxorubicin—uterine cancer	2.98e-05	0.000985	CcSEcCtD
Daunorubicin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	2.97e-05	0.000982	CcSEcCtD
Daunorubicin—Abnormal vision—Doxorubicin—uterine cancer	2.97e-05	0.00098	CcSEcCtD
Daunorubicin—Eye pain—Epirubicin—uterine cancer	2.96e-05	0.000976	CcSEcCtD
Daunorubicin—Chills—Etoposide—uterine cancer	2.95e-05	0.000976	CcSEcCtD
Daunorubicin—Mental disability—Doxorubicin—uterine cancer	2.95e-05	0.000975	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	2.95e-05	0.000973	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Epirubicin—uterine cancer	2.94e-05	0.000972	CcSEcCtD
Daunorubicin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	2.93e-05	0.000968	CcSEcCtD
Daunorubicin—Alopecia—Etoposide—uterine cancer	2.91e-05	0.000961	CcSEcCtD
Daunorubicin—Vomiting—Progesterone—uterine cancer	2.91e-05	0.00096	CcSEcCtD
Daunorubicin—Lymphadenopathy—Doxorubicin—uterine cancer	2.89e-05	0.000956	CcSEcCtD
Daunorubicin—Rash—Progesterone—uterine cancer	2.88e-05	0.000952	CcSEcCtD
Daunorubicin—Dermatitis—Progesterone—uterine cancer	2.88e-05	0.000951	CcSEcCtD
Daunorubicin—Headache—Progesterone—uterine cancer	2.87e-05	0.000946	CcSEcCtD
Daunorubicin—Hot flush—Epirubicin—uterine cancer	2.85e-05	0.000942	CcSEcCtD
Daunorubicin—Thrombophlebitis—Doxorubicin—uterine cancer	2.85e-05	0.000942	CcSEcCtD
Daunorubicin—Increased appetite—Epirubicin—uterine cancer	2.84e-05	0.000938	CcSEcCtD
Daunorubicin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	2.84e-05	0.000936	CcSEcCtD
Daunorubicin—Menopausal symptoms—Epirubicin—uterine cancer	2.83e-05	0.000934	CcSEcCtD
Daunorubicin—Hepatic function abnormal—Doxorubicin—uterine cancer	2.83e-05	0.000933	CcSEcCtD
Daunorubicin—TOP2A—Methyltestosterone—Progesterone—uterine cancer	2.81e-05	0.0393	CbGdCrCtD
Daunorubicin—Decreased appetite—Dactinomycin—uterine cancer	2.81e-05	0.000928	CcSEcCtD
Daunorubicin—Dysgeusia—Etoposide—uterine cancer	2.81e-05	0.000927	CcSEcCtD
Daunorubicin—Renal impairment—Epirubicin—uterine cancer	2.8e-05	0.000926	CcSEcCtD
Daunorubicin—Fatigue—Dactinomycin—uterine cancer	2.79e-05	0.00092	CcSEcCtD
Daunorubicin—Back pain—Etoposide—uterine cancer	2.77e-05	0.000916	CcSEcCtD
Daunorubicin—Pain—Dactinomycin—uterine cancer	2.76e-05	0.000913	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Epirubicin—uterine cancer	2.76e-05	0.00091	CcSEcCtD
Daunorubicin—ABCB1—female reproductive system—uterine cancer	2.74e-05	0.00166	CbGeAlD
Daunorubicin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	2.74e-05	0.000905	CcSEcCtD
Daunorubicin—Eye pain—Doxorubicin—uterine cancer	2.73e-05	0.000903	CcSEcCtD
Daunorubicin—Cardiac failure—Epirubicin—uterine cancer	2.73e-05	0.000903	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Doxorubicin—uterine cancer	2.72e-05	0.000899	CcSEcCtD
Daunorubicin—Nausea—Progesterone—uterine cancer	2.72e-05	0.000897	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	2.67e-05	0.000881	CcSEcCtD
Daunorubicin—Feeling abnormal—Dactinomycin—uterine cancer	2.66e-05	0.00088	CcSEcCtD
Daunorubicin—Ill-defined disorder—Etoposide—uterine cancer	2.66e-05	0.000878	CcSEcCtD
Daunorubicin—Anaemia—Etoposide—uterine cancer	2.65e-05	0.000875	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Dactinomycin—uterine cancer	2.64e-05	0.000873	CcSEcCtD
Daunorubicin—Hot flush—Doxorubicin—uterine cancer	2.64e-05	0.000872	CcSEcCtD
Daunorubicin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	2.64e-05	0.00087	CcSEcCtD
Daunorubicin—Increased appetite—Doxorubicin—uterine cancer	2.63e-05	0.000868	CcSEcCtD
Daunorubicin—Affect lability—Epirubicin—uterine cancer	2.63e-05	0.000867	CcSEcCtD
Daunorubicin—Menopausal symptoms—Doxorubicin—uterine cancer	2.62e-05	0.000864	CcSEcCtD
Daunorubicin—Rash—Medroxyprogesterone Acetate—uterine cancer	2.61e-05	0.000863	CcSEcCtD
Daunorubicin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	2.61e-05	0.000862	CcSEcCtD
Daunorubicin—Headache—Medroxyprogesterone Acetate—uterine cancer	2.6e-05	0.000857	CcSEcCtD
Daunorubicin—Renal impairment—Doxorubicin—uterine cancer	2.59e-05	0.000857	CcSEcCtD
Daunorubicin—Malaise—Etoposide—uterine cancer	2.59e-05	0.000854	CcSEcCtD
Daunorubicin—Leukopenia—Etoposide—uterine cancer	2.57e-05	0.000847	CcSEcCtD
Daunorubicin—Abdominal pain—Dactinomycin—uterine cancer	2.56e-05	0.000844	CcSEcCtD
Daunorubicin—Body temperature increased—Dactinomycin—uterine cancer	2.56e-05	0.000844	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Doxorubicin—uterine cancer	2.55e-05	0.000842	CcSEcCtD
Daunorubicin—Cardiac arrest—Epirubicin—uterine cancer	2.54e-05	0.000838	CcSEcCtD
Daunorubicin—Cardiac failure—Doxorubicin—uterine cancer	2.53e-05	0.000835	CcSEcCtD
Daunorubicin—Mood swings—Epirubicin—uterine cancer	2.53e-05	0.000835	CcSEcCtD
Daunorubicin—Loss of consciousness—Etoposide—uterine cancer	2.52e-05	0.000832	CcSEcCtD
Daunorubicin—Ataxia—Epirubicin—uterine cancer	2.51e-05	0.000829	CcSEcCtD
Daunorubicin—Cough—Etoposide—uterine cancer	2.5e-05	0.000826	CcSEcCtD
Daunorubicin—ABCB1—female gonad—uterine cancer	2.5e-05	0.00151	CbGeAlD
Daunorubicin—Convulsion—Etoposide—uterine cancer	2.48e-05	0.00082	CcSEcCtD
Daunorubicin—Dehydration—Epirubicin—uterine cancer	2.48e-05	0.00082	CcSEcCtD
Daunorubicin—ABCB1—vagina—uterine cancer	2.48e-05	0.0015	CbGeAlD
Daunorubicin—Hypertension—Etoposide—uterine cancer	2.48e-05	0.000817	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	2.47e-05	0.000815	CcSEcCtD
Daunorubicin—Nausea—Medroxyprogesterone Acetate—uterine cancer	2.46e-05	0.000813	CcSEcCtD
Daunorubicin—Dry skin—Epirubicin—uterine cancer	2.45e-05	0.000808	CcSEcCtD
Daunorubicin—Chest pain—Etoposide—uterine cancer	2.44e-05	0.000806	CcSEcCtD
Daunorubicin—Affect lability—Doxorubicin—uterine cancer	2.43e-05	0.000803	CcSEcCtD
Daunorubicin—Discomfort—Etoposide—uterine cancer	2.41e-05	0.000796	CcSEcCtD
Daunorubicin—Hypersensitivity—Dactinomycin—uterine cancer	2.38e-05	0.000787	CcSEcCtD
Daunorubicin—Gastritis—Epirubicin—uterine cancer	2.36e-05	0.00078	CcSEcCtD
Daunorubicin—Confusional state—Etoposide—uterine cancer	2.36e-05	0.000779	CcSEcCtD
Daunorubicin—Cardiac arrest—Doxorubicin—uterine cancer	2.35e-05	0.000775	CcSEcCtD
Daunorubicin—Anaphylactic shock—Etoposide—uterine cancer	2.34e-05	0.000773	CcSEcCtD
Daunorubicin—Mood swings—Doxorubicin—uterine cancer	2.34e-05	0.000772	CcSEcCtD
Daunorubicin—Infection—Etoposide—uterine cancer	2.32e-05	0.000768	CcSEcCtD
Daunorubicin—Ataxia—Doxorubicin—uterine cancer	2.32e-05	0.000767	CcSEcCtD
Daunorubicin—Asthenia—Dactinomycin—uterine cancer	2.32e-05	0.000766	CcSEcCtD
Daunorubicin—Dysphagia—Epirubicin—uterine cancer	2.31e-05	0.000762	CcSEcCtD
Daunorubicin—Dehydration—Doxorubicin—uterine cancer	2.3e-05	0.000758	CcSEcCtD
Daunorubicin—Thrombocytopenia—Etoposide—uterine cancer	2.29e-05	0.000757	CcSEcCtD
Daunorubicin—Tachycardia—Etoposide—uterine cancer	2.28e-05	0.000754	CcSEcCtD
Daunorubicin—Dry skin—Doxorubicin—uterine cancer	2.26e-05	0.000747	CcSEcCtD
Daunorubicin—Hyperhidrosis—Etoposide—uterine cancer	2.26e-05	0.000747	CcSEcCtD
Daunorubicin—Angina pectoris—Epirubicin—uterine cancer	2.25e-05	0.000742	CcSEcCtD
Daunorubicin—Anorexia—Etoposide—uterine cancer	2.23e-05	0.000736	CcSEcCtD
Daunorubicin—Diarrhoea—Dactinomycin—uterine cancer	2.21e-05	0.00073	CcSEcCtD
Daunorubicin—Pancytopenia—Epirubicin—uterine cancer	2.19e-05	0.000723	CcSEcCtD
Daunorubicin—Gastritis—Doxorubicin—uterine cancer	2.19e-05	0.000722	CcSEcCtD
Daunorubicin—Dysuria—Epirubicin—uterine cancer	2.16e-05	0.000712	CcSEcCtD
Daunorubicin—Neutropenia—Epirubicin—uterine cancer	2.16e-05	0.000712	CcSEcCtD
Daunorubicin—Dysphagia—Doxorubicin—uterine cancer	2.13e-05	0.000705	CcSEcCtD
Daunorubicin—Dyspnoea—Etoposide—uterine cancer	2.09e-05	0.000689	CcSEcCtD
Daunorubicin—Somnolence—Etoposide—uterine cancer	2.08e-05	0.000687	CcSEcCtD
Daunorubicin—Angina pectoris—Doxorubicin—uterine cancer	2.08e-05	0.000686	CcSEcCtD
Daunorubicin—TOP2A—Idarubicin—Epirubicin—uterine cancer	2.06e-05	0.0289	CbGdCrCtD
Daunorubicin—TOP2A—Doxorubicin—Epirubicin—uterine cancer	2.06e-05	0.0289	CbGdCrCtD
Daunorubicin—Vomiting—Dactinomycin—uterine cancer	2.06e-05	0.000679	CcSEcCtD
Daunorubicin—Rash—Dactinomycin—uterine cancer	2.04e-05	0.000673	CcSEcCtD
Daunorubicin—Decreased appetite—Etoposide—uterine cancer	2.03e-05	0.000672	CcSEcCtD
Daunorubicin—Pancytopenia—Doxorubicin—uterine cancer	2.03e-05	0.000669	CcSEcCtD
Daunorubicin—Renal failure—Epirubicin—uterine cancer	2.02e-05	0.000668	CcSEcCtD
Daunorubicin—Fatigue—Etoposide—uterine cancer	2.02e-05	0.000666	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Epirubicin—uterine cancer	2.02e-05	0.000666	CcSEcCtD
Daunorubicin—Stomatitis—Epirubicin—uterine cancer	2e-05	0.000662	CcSEcCtD
Daunorubicin—Pain—Etoposide—uterine cancer	2e-05	0.000661	CcSEcCtD
Daunorubicin—Constipation—Etoposide—uterine cancer	2e-05	0.000661	CcSEcCtD
Daunorubicin—Conjunctivitis—Epirubicin—uterine cancer	2e-05	0.00066	CcSEcCtD
Daunorubicin—Dysuria—Doxorubicin—uterine cancer	2e-05	0.000659	CcSEcCtD
Daunorubicin—Neutropenia—Doxorubicin—uterine cancer	2e-05	0.000659	CcSEcCtD
Daunorubicin—Sinusitis—Epirubicin—uterine cancer	1.93e-05	0.000637	CcSEcCtD
Daunorubicin—Feeling abnormal—Etoposide—uterine cancer	1.93e-05	0.000637	CcSEcCtD
Daunorubicin—Nausea—Dactinomycin—uterine cancer	1.92e-05	0.000634	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Etoposide—uterine cancer	1.91e-05	0.000632	CcSEcCtD
Daunorubicin—TOP2A—Idarubicin—Doxorubicin—uterine cancer	1.91e-05	0.0267	CbGdCrCtD
Daunorubicin—TOP2A—Epirubicin—Doxorubicin—uterine cancer	1.91e-05	0.0267	CbGdCrCtD
Daunorubicin—Renal failure—Doxorubicin—uterine cancer	1.87e-05	0.000618	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Doxorubicin—uterine cancer	1.87e-05	0.000616	CcSEcCtD
Daunorubicin—Urticaria—Etoposide—uterine cancer	1.86e-05	0.000614	CcSEcCtD
Daunorubicin—Stomatitis—Doxorubicin—uterine cancer	1.85e-05	0.000612	CcSEcCtD
Daunorubicin—Rhinitis—Epirubicin—uterine cancer	1.85e-05	0.000611	CcSEcCtD
Daunorubicin—Abdominal pain—Etoposide—uterine cancer	1.85e-05	0.000611	CcSEcCtD
Daunorubicin—Body temperature increased—Etoposide—uterine cancer	1.85e-05	0.000611	CcSEcCtD
Daunorubicin—Conjunctivitis—Doxorubicin—uterine cancer	1.85e-05	0.000611	CcSEcCtD
Daunorubicin—TOP2A—Norethindrone—Progesterone—uterine cancer	1.83e-05	0.0257	CbGdCrCtD
Daunorubicin—Sinusitis—Doxorubicin—uterine cancer	1.79e-05	0.000589	CcSEcCtD
Daunorubicin—Visual impairment—Epirubicin—uterine cancer	1.78e-05	0.000587	CcSEcCtD
Daunorubicin—Hypersensitivity—Etoposide—uterine cancer	1.72e-05	0.000569	CcSEcCtD
Daunorubicin—Tinnitus—Epirubicin—uterine cancer	1.72e-05	0.000568	CcSEcCtD
Daunorubicin—Flushing—Epirubicin—uterine cancer	1.71e-05	0.000566	CcSEcCtD
Daunorubicin—Cardiac disorder—Epirubicin—uterine cancer	1.71e-05	0.000566	CcSEcCtD
Daunorubicin—Rhinitis—Doxorubicin—uterine cancer	1.71e-05	0.000565	CcSEcCtD
Daunorubicin—Asthenia—Etoposide—uterine cancer	1.68e-05	0.000554	CcSEcCtD
Daunorubicin—Chills—Epirubicin—uterine cancer	1.66e-05	0.000547	CcSEcCtD
Daunorubicin—Pruritus—Etoposide—uterine cancer	1.66e-05	0.000547	CcSEcCtD
Daunorubicin—Arrhythmia—Epirubicin—uterine cancer	1.65e-05	0.000545	CcSEcCtD
Daunorubicin—Visual impairment—Doxorubicin—uterine cancer	1.65e-05	0.000544	CcSEcCtD
Daunorubicin—Alopecia—Epirubicin—uterine cancer	1.63e-05	0.000539	CcSEcCtD
Daunorubicin—Erythema—Epirubicin—uterine cancer	1.61e-05	0.000531	CcSEcCtD
Daunorubicin—ABCB1—lymph node—uterine cancer	1.61e-05	0.00097	CbGeAlD
Daunorubicin—Diarrhoea—Etoposide—uterine cancer	1.6e-05	0.000529	CcSEcCtD
Daunorubicin—Tinnitus—Doxorubicin—uterine cancer	1.59e-05	0.000526	CcSEcCtD
Daunorubicin—Flushing—Doxorubicin—uterine cancer	1.59e-05	0.000523	CcSEcCtD
Daunorubicin—Cardiac disorder—Doxorubicin—uterine cancer	1.59e-05	0.000523	CcSEcCtD
Daunorubicin—Dysgeusia—Epirubicin—uterine cancer	1.57e-05	0.00052	CcSEcCtD
Daunorubicin—Back pain—Epirubicin—uterine cancer	1.55e-05	0.000513	CcSEcCtD
Daunorubicin—Dizziness—Etoposide—uterine cancer	1.55e-05	0.000511	CcSEcCtD
Daunorubicin—Chills—Doxorubicin—uterine cancer	1.53e-05	0.000506	CcSEcCtD
Daunorubicin—Arrhythmia—Doxorubicin—uterine cancer	1.53e-05	0.000504	CcSEcCtD
Daunorubicin—Alopecia—Doxorubicin—uterine cancer	1.51e-05	0.000498	CcSEcCtD
Daunorubicin—Ill-defined disorder—Epirubicin—uterine cancer	1.49e-05	0.000492	CcSEcCtD
Daunorubicin—Vomiting—Etoposide—uterine cancer	1.49e-05	0.000491	CcSEcCtD
Daunorubicin—Erythema—Doxorubicin—uterine cancer	1.49e-05	0.000491	CcSEcCtD
Daunorubicin—Anaemia—Epirubicin—uterine cancer	1.49e-05	0.00049	CcSEcCtD
Daunorubicin—Agitation—Epirubicin—uterine cancer	1.48e-05	0.000488	CcSEcCtD
Daunorubicin—Rash—Etoposide—uterine cancer	1.48e-05	0.000487	CcSEcCtD
Daunorubicin—Dermatitis—Etoposide—uterine cancer	1.47e-05	0.000487	CcSEcCtD
Daunorubicin—Headache—Etoposide—uterine cancer	1.47e-05	0.000484	CcSEcCtD
Daunorubicin—TOP2A—Levonorgestrel—Progesterone—uterine cancer	1.46e-05	0.0204	CbGdCrCtD
Daunorubicin—Dysgeusia—Doxorubicin—uterine cancer	1.46e-05	0.000481	CcSEcCtD
Daunorubicin—Malaise—Epirubicin—uterine cancer	1.45e-05	0.000479	CcSEcCtD
Daunorubicin—Syncope—Epirubicin—uterine cancer	1.44e-05	0.000476	CcSEcCtD
Daunorubicin—Leukopenia—Epirubicin—uterine cancer	1.44e-05	0.000475	CcSEcCtD
Daunorubicin—Back pain—Doxorubicin—uterine cancer	1.44e-05	0.000475	CcSEcCtD
Daunorubicin—Palpitations—Epirubicin—uterine cancer	1.42e-05	0.000469	CcSEcCtD
Daunorubicin—Loss of consciousness—Epirubicin—uterine cancer	1.41e-05	0.000466	CcSEcCtD
Daunorubicin—Cough—Epirubicin—uterine cancer	1.4e-05	0.000463	CcSEcCtD
Daunorubicin—Convulsion—Epirubicin—uterine cancer	1.39e-05	0.00046	CcSEcCtD
Daunorubicin—Nausea—Etoposide—uterine cancer	1.39e-05	0.000459	CcSEcCtD
Daunorubicin—Hypertension—Epirubicin—uterine cancer	1.39e-05	0.000458	CcSEcCtD
Daunorubicin—Ill-defined disorder—Doxorubicin—uterine cancer	1.38e-05	0.000456	CcSEcCtD
Daunorubicin—Anaemia—Doxorubicin—uterine cancer	1.37e-05	0.000454	CcSEcCtD
Daunorubicin—Arthralgia—Epirubicin—uterine cancer	1.37e-05	0.000452	CcSEcCtD
Daunorubicin—Chest pain—Epirubicin—uterine cancer	1.37e-05	0.000452	CcSEcCtD
Daunorubicin—Myalgia—Epirubicin—uterine cancer	1.37e-05	0.000452	CcSEcCtD
Daunorubicin—Agitation—Doxorubicin—uterine cancer	1.37e-05	0.000451	CcSEcCtD
Daunorubicin—Anxiety—Epirubicin—uterine cancer	1.36e-05	0.00045	CcSEcCtD
Daunorubicin—Discomfort—Epirubicin—uterine cancer	1.35e-05	0.000446	CcSEcCtD
Daunorubicin—Malaise—Doxorubicin—uterine cancer	1.34e-05	0.000443	CcSEcCtD
Daunorubicin—Dry mouth—Epirubicin—uterine cancer	1.34e-05	0.000442	CcSEcCtD
Daunorubicin—Syncope—Doxorubicin—uterine cancer	1.33e-05	0.00044	CcSEcCtD
Daunorubicin—Leukopenia—Doxorubicin—uterine cancer	1.33e-05	0.00044	CcSEcCtD
Daunorubicin—Confusional state—Epirubicin—uterine cancer	1.32e-05	0.000437	CcSEcCtD
Daunorubicin—Palpitations—Doxorubicin—uterine cancer	1.31e-05	0.000434	CcSEcCtD
Daunorubicin—Oedema—Epirubicin—uterine cancer	1.31e-05	0.000433	CcSEcCtD
Daunorubicin—Anaphylactic shock—Epirubicin—uterine cancer	1.31e-05	0.000433	CcSEcCtD
Daunorubicin—Loss of consciousness—Doxorubicin—uterine cancer	1.31e-05	0.000432	CcSEcCtD
Daunorubicin—Infection—Epirubicin—uterine cancer	1.3e-05	0.00043	CcSEcCtD
Daunorubicin—Cough—Doxorubicin—uterine cancer	1.3e-05	0.000428	CcSEcCtD
Daunorubicin—Shock—Epirubicin—uterine cancer	1.29e-05	0.000426	CcSEcCtD
Daunorubicin—Convulsion—Doxorubicin—uterine cancer	1.29e-05	0.000425	CcSEcCtD
Daunorubicin—Thrombocytopenia—Epirubicin—uterine cancer	1.28e-05	0.000424	CcSEcCtD
Daunorubicin—Hypertension—Doxorubicin—uterine cancer	1.28e-05	0.000424	CcSEcCtD
Daunorubicin—Tachycardia—Epirubicin—uterine cancer	1.28e-05	0.000423	CcSEcCtD
Daunorubicin—Hyperhidrosis—Epirubicin—uterine cancer	1.27e-05	0.000419	CcSEcCtD
Daunorubicin—Arthralgia—Doxorubicin—uterine cancer	1.27e-05	0.000418	CcSEcCtD
Daunorubicin—Chest pain—Doxorubicin—uterine cancer	1.27e-05	0.000418	CcSEcCtD
Daunorubicin—Myalgia—Doxorubicin—uterine cancer	1.27e-05	0.000418	CcSEcCtD
Daunorubicin—Anxiety—Doxorubicin—uterine cancer	1.26e-05	0.000417	CcSEcCtD
Daunorubicin—Discomfort—Doxorubicin—uterine cancer	1.25e-05	0.000413	CcSEcCtD
Daunorubicin—Anorexia—Epirubicin—uterine cancer	1.25e-05	0.000413	CcSEcCtD
Daunorubicin—Dry mouth—Doxorubicin—uterine cancer	1.24e-05	0.000409	CcSEcCtD
Daunorubicin—Confusional state—Doxorubicin—uterine cancer	1.22e-05	0.000404	CcSEcCtD
Daunorubicin—Anaphylactic shock—Doxorubicin—uterine cancer	1.21e-05	0.000401	CcSEcCtD
Daunorubicin—Oedema—Doxorubicin—uterine cancer	1.21e-05	0.000401	CcSEcCtD
Daunorubicin—Infection—Doxorubicin—uterine cancer	1.21e-05	0.000398	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Epirubicin—uterine cancer	1.19e-05	0.000395	CcSEcCtD
Daunorubicin—Shock—Doxorubicin—uterine cancer	1.19e-05	0.000394	CcSEcCtD
Daunorubicin—Thrombocytopenia—Doxorubicin—uterine cancer	1.19e-05	0.000392	CcSEcCtD
Daunorubicin—Insomnia—Epirubicin—uterine cancer	1.19e-05	0.000392	CcSEcCtD
Daunorubicin—Tachycardia—Doxorubicin—uterine cancer	1.18e-05	0.000391	CcSEcCtD
Daunorubicin—Hyperhidrosis—Doxorubicin—uterine cancer	1.17e-05	0.000387	CcSEcCtD
Daunorubicin—Dyspnoea—Epirubicin—uterine cancer	1.17e-05	0.000386	CcSEcCtD
Daunorubicin—Somnolence—Epirubicin—uterine cancer	1.17e-05	0.000385	CcSEcCtD
Daunorubicin—Anorexia—Doxorubicin—uterine cancer	1.16e-05	0.000382	CcSEcCtD
Daunorubicin—Decreased appetite—Epirubicin—uterine cancer	1.14e-05	0.000376	CcSEcCtD
Daunorubicin—Fatigue—Epirubicin—uterine cancer	1.13e-05	0.000373	CcSEcCtD
Daunorubicin—Constipation—Epirubicin—uterine cancer	1.12e-05	0.00037	CcSEcCtD
Daunorubicin—Pain—Epirubicin—uterine cancer	1.12e-05	0.00037	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	1.11e-05	0.000365	CcSEcCtD
Daunorubicin—Insomnia—Doxorubicin—uterine cancer	1.1e-05	0.000362	CcSEcCtD
Daunorubicin—Dyspnoea—Doxorubicin—uterine cancer	1.08e-05	0.000357	CcSEcCtD
Daunorubicin—Feeling abnormal—Epirubicin—uterine cancer	1.08e-05	0.000357	CcSEcCtD
Daunorubicin—Somnolence—Doxorubicin—uterine cancer	1.08e-05	0.000356	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Epirubicin—uterine cancer	1.07e-05	0.000354	CcSEcCtD
Daunorubicin—Decreased appetite—Doxorubicin—uterine cancer	1.05e-05	0.000348	CcSEcCtD
Daunorubicin—Fatigue—Doxorubicin—uterine cancer	1.05e-05	0.000346	CcSEcCtD
Daunorubicin—Urticaria—Epirubicin—uterine cancer	1.04e-05	0.000344	CcSEcCtD
Daunorubicin—Pain—Doxorubicin—uterine cancer	1.04e-05	0.000343	CcSEcCtD
Daunorubicin—Constipation—Doxorubicin—uterine cancer	1.04e-05	0.000343	CcSEcCtD
Daunorubicin—Abdominal pain—Epirubicin—uterine cancer	1.04e-05	0.000342	CcSEcCtD
Daunorubicin—Body temperature increased—Epirubicin—uterine cancer	1.04e-05	0.000342	CcSEcCtD
Daunorubicin—Feeling abnormal—Doxorubicin—uterine cancer	1e-05	0.00033	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Doxorubicin—uterine cancer	9.92e-06	0.000328	CcSEcCtD
Daunorubicin—Hypersensitivity—Epirubicin—uterine cancer	9.66e-06	0.000319	CcSEcCtD
Daunorubicin—Urticaria—Doxorubicin—uterine cancer	9.64e-06	0.000318	CcSEcCtD
Daunorubicin—Body temperature increased—Doxorubicin—uterine cancer	9.59e-06	0.000317	CcSEcCtD
Daunorubicin—Abdominal pain—Doxorubicin—uterine cancer	9.59e-06	0.000317	CcSEcCtD
Daunorubicin—Asthenia—Epirubicin—uterine cancer	9.41e-06	0.000311	CcSEcCtD
Daunorubicin—Pruritus—Epirubicin—uterine cancer	9.28e-06	0.000306	CcSEcCtD
Daunorubicin—Diarrhoea—Epirubicin—uterine cancer	8.97e-06	0.000296	CcSEcCtD
Daunorubicin—Hypersensitivity—Doxorubicin—uterine cancer	8.94e-06	0.000295	CcSEcCtD
Daunorubicin—Asthenia—Doxorubicin—uterine cancer	8.71e-06	0.000288	CcSEcCtD
Daunorubicin—Dizziness—Epirubicin—uterine cancer	8.67e-06	0.000286	CcSEcCtD
Daunorubicin—Pruritus—Doxorubicin—uterine cancer	8.59e-06	0.000284	CcSEcCtD
Daunorubicin—Vomiting—Epirubicin—uterine cancer	8.34e-06	0.000275	CcSEcCtD
Daunorubicin—Diarrhoea—Doxorubicin—uterine cancer	8.3e-06	0.000274	CcSEcCtD
Daunorubicin—Rash—Epirubicin—uterine cancer	8.27e-06	0.000273	CcSEcCtD
Daunorubicin—Dermatitis—Epirubicin—uterine cancer	8.26e-06	0.000273	CcSEcCtD
Daunorubicin—Headache—Epirubicin—uterine cancer	8.22e-06	0.000271	CcSEcCtD
Daunorubicin—Dizziness—Doxorubicin—uterine cancer	8.02e-06	0.000265	CcSEcCtD
Daunorubicin—Nausea—Epirubicin—uterine cancer	7.79e-06	0.000257	CcSEcCtD
Daunorubicin—Vomiting—Doxorubicin—uterine cancer	7.72e-06	0.000255	CcSEcCtD
Daunorubicin—Rash—Doxorubicin—uterine cancer	7.65e-06	0.000253	CcSEcCtD
Daunorubicin—Dermatitis—Doxorubicin—uterine cancer	7.64e-06	0.000252	CcSEcCtD
Daunorubicin—Headache—Doxorubicin—uterine cancer	7.6e-06	0.000251	CcSEcCtD
Daunorubicin—Nausea—Doxorubicin—uterine cancer	7.21e-06	0.000238	CcSEcCtD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	5.81e-06	0.000355	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.77e-06	0.000352	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—AKT1—uterine cancer	5.75e-06	0.000351	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.73e-06	0.00035	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	5.71e-06	0.000348	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKR1C1—uterine cancer	5.7e-06	0.000348	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	5.69e-06	0.000348	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKR1B1—uterine cancer	5.65e-06	0.000345	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—STAR—uterine cancer	5.65e-06	0.000345	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	5.63e-06	0.000344	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDKN1B—uterine cancer	5.61e-06	0.000342	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.58e-06	0.000341	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	5.57e-06	0.00034	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—EP300—uterine cancer	5.51e-06	0.000336	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—uterine cancer	5.47e-06	0.000334	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	5.26e-06	0.000321	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKR1B1—uterine cancer	5.14e-06	0.000314	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—STAR—uterine cancer	5.14e-06	0.000314	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKR1C1—uterine cancer	5.12e-06	0.000312	CbGpPWpGaD
Daunorubicin—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	5.1e-06	0.000311	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SRD5A2—uterine cancer	5.09e-06	0.000311	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NDUFB11—uterine cancer	5.09e-06	0.000311	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKR1B1—uterine cancer	5.08e-06	0.00031	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—RRM2—uterine cancer	5.08e-06	0.00031	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—STAR—uterine cancer	5.08e-06	0.00031	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—VEGFA—uterine cancer	5.03e-06	0.000307	CbGpPWpGaD
Daunorubicin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	4.99e-06	0.000305	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.98e-06	0.000304	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.98e-06	0.000304	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—uterine cancer	4.95e-06	0.000302	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—DCN—uterine cancer	4.93e-06	0.000301	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—EP300—uterine cancer	4.93e-06	0.000301	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.81e-06	0.000294	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SRD5A2—uterine cancer	4.81e-06	0.000294	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NDUFB11—uterine cancer	4.81e-06	0.000294	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.67e-06	0.000285	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP11A1—uterine cancer	4.65e-06	0.000284	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—STK11—uterine cancer	4.64e-06	0.000283	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CYP19A1—uterine cancer	4.64e-06	0.000283	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—POLD1—uterine cancer	4.58e-06	0.00028	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	4.47e-06	0.000273	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—POLD1—uterine cancer	4.43e-06	0.00027	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDKN2A—uterine cancer	4.43e-06	0.00027	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—DCN—uterine cancer	4.43e-06	0.00027	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.41e-06	0.000269	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.4e-06	0.000269	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKR1C3—uterine cancer	4.39e-06	0.000268	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	4.39e-06	0.000268	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—uterine cancer	4.39e-06	0.000268	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.34e-06	0.000265	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKR1C1—uterine cancer	4.28e-06	0.000262	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKR1C1—uterine cancer	4.14e-06	0.000253	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—POLD1—uterine cancer	4.03e-06	0.000246	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—POLD1—uterine cancer	3.99e-06	0.000244	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKR1C3—uterine cancer	3.94e-06	0.00024	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDKN1B—uterine cancer	3.92e-06	0.00024	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—EP300—uterine cancer	3.85e-06	0.000235	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SRD5A2—uterine cancer	3.84e-06	0.000234	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NDUFB11—uterine cancer	3.84e-06	0.000234	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HMGA1—uterine cancer	3.84e-06	0.000234	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—RRM2—uterine cancer	3.82e-06	0.000233	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKR1C1—uterine cancer	3.77e-06	0.00023	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKR1C1—uterine cancer	3.73e-06	0.000228	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—DCN—uterine cancer	3.71e-06	0.000226	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	3.71e-06	0.000226	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—RRM2—uterine cancer	3.69e-06	0.000225	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKR1B1—uterine cancer	3.68e-06	0.000225	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—STAR—uterine cancer	3.68e-06	0.000225	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.65e-06	0.000223	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—DCN—uterine cancer	3.59e-06	0.000219	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—uterine cancer	3.52e-06	0.000215	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FBXW7—uterine cancer	3.51e-06	0.000214	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP11A1—uterine cancer	3.49e-06	0.000213	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—MTHFR—uterine cancer	3.49e-06	0.000213	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKR1B1—uterine cancer	3.48e-06	0.000212	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—STAR—uterine cancer	3.48e-06	0.000212	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—EP300—uterine cancer	3.44e-06	0.00021	CbGpPWpGaD
Daunorubicin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	3.44e-06	0.00021	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.44e-06	0.00021	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—STK11—uterine cancer	3.42e-06	0.000209	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP19A1—uterine cancer	3.42e-06	0.000209	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP11A1—uterine cancer	3.38e-06	0.000206	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—RRM2—uterine cancer	3.36e-06	0.000205	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—RRM2—uterine cancer	3.33e-06	0.000203	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKR1C3—uterine cancer	3.3e-06	0.000201	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—DCN—uterine cancer	3.26e-06	0.000199	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—DCN—uterine cancer	3.23e-06	0.000197	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	3.22e-06	0.000197	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.21e-06	0.000196	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKR1C3—uterine cancer	3.19e-06	0.000195	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	3.16e-06	0.000193	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP11A1—uterine cancer	3.07e-06	0.000188	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SRD5A2—uterine cancer	3.07e-06	0.000187	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NDUFB11—uterine cancer	3.07e-06	0.000187	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.06e-06	0.000187	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP11A1—uterine cancer	3.04e-06	0.000186	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.98e-06	0.000182	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.98e-06	0.000182	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—AKT1—uterine cancer	2.94e-06	0.00018	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKR1C3—uterine cancer	2.9e-06	0.000177	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—POLD1—uterine cancer	2.89e-06	0.000176	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKR1C3—uterine cancer	2.87e-06	0.000175	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.82e-06	0.000172	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.81e-06	0.000172	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKR1B1—uterine cancer	2.78e-06	0.00017	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—STAR—uterine cancer	2.78e-06	0.00017	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN2B—uterine cancer	2.75e-06	0.000168	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.75e-06	0.000168	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—POLD1—uterine cancer	2.73e-06	0.000167	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKR1C1—uterine cancer	2.7e-06	0.000165	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.62e-06	0.00016	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—MTHFR—uterine cancer	2.57e-06	0.000157	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP19A1—uterine cancer	2.57e-06	0.000157	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—STK11—uterine cancer	2.57e-06	0.000157	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKR1C1—uterine cancer	2.55e-06	0.000156	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SMAD3—uterine cancer	2.51e-06	0.000153	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—STK11—uterine cancer	2.48e-06	0.000152	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP19A1—uterine cancer	2.48e-06	0.000152	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.48e-06	0.000152	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—uterine cancer	2.47e-06	0.000151	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—HRAS—uterine cancer	2.42e-06	0.000148	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.41e-06	0.000147	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—RRM2—uterine cancer	2.41e-06	0.000147	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FGFR2—uterine cancer	2.39e-06	0.000146	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.37e-06	0.000144	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.37e-06	0.000144	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—DCN—uterine cancer	2.34e-06	0.000143	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.33e-06	0.000142	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MTHFR—uterine cancer	2.31e-06	0.000141	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.3e-06	0.00014	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—RRM2—uterine cancer	2.27e-06	0.000139	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.26e-06	0.000138	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP19A1—uterine cancer	2.26e-06	0.000138	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—STK11—uterine cancer	2.26e-06	0.000138	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—STK11—uterine cancer	2.24e-06	0.000137	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP19A1—uterine cancer	2.24e-06	0.000137	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.22e-06	0.000136	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKR1B1—uterine cancer	2.22e-06	0.000135	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—STAR—uterine cancer	2.22e-06	0.000135	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—DCN—uterine cancer	2.21e-06	0.000135	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP11A1—uterine cancer	2.2e-06	0.000134	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.19e-06	0.000134	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—POLD1—uterine cancer	2.18e-06	0.000133	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.11e-06	0.000129	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP11A1—uterine cancer	2.08e-06	0.000127	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKR1C3—uterine cancer	2.08e-06	0.000127	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKR1C1—uterine cancer	2.04e-06	0.000124	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKR1C3—uterine cancer	1.96e-06	0.00012	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTEN—uterine cancer	1.94e-06	0.000118	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.94e-06	0.000118	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—MTHFR—uterine cancer	1.93e-06	0.000118	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.88e-06	0.000114	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—MTHFR—uterine cancer	1.87e-06	0.000114	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—EP300—uterine cancer	1.85e-06	0.000113	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—RRM2—uterine cancer	1.82e-06	0.000111	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—DCN—uterine cancer	1.76e-06	0.000108	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—POLD1—uterine cancer	1.74e-06	0.000106	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—STAR—uterine cancer	1.71e-06	0.000104	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.71e-06	0.000104	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.7e-06	0.000104	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—MTHFR—uterine cancer	1.7e-06	0.000104	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—MTHFR—uterine cancer	1.68e-06	0.000103	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP11A1—uterine cancer	1.66e-06	0.000101	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.65e-06	0.0001	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.63e-06	9.93e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—STK11—uterine cancer	1.62e-06	9.89e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.62e-06	9.89e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.58e-06	9.67e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKR1C3—uterine cancer	1.57e-06	9.58e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—STK11—uterine cancer	1.53e-06	9.34e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.53e-06	9.34e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ERBB2—uterine cancer	1.5e-06	9.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—RRM2—uterine cancer	1.45e-06	8.85e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.44e-06	8.77e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTEN—uterine cancer	1.43e-06	8.73e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—DCN—uterine cancer	1.41e-06	8.59e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1B—uterine cancer	1.39e-06	8.5e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.37e-06	8.36e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CA—uterine cancer	1.37e-06	8.35e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—EP300—uterine cancer	1.36e-06	8.32e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—POLD1—uterine cancer	1.34e-06	8.2e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.33e-06	8.1e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CTNNB1—uterine cancer	1.32e-06	8.03e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTEN—uterine cancer	1.28e-06	7.83e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.26e-06	7.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.25e-06	7.65e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EP300—uterine cancer	1.22e-06	7.47e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—STK11—uterine cancer	1.22e-06	7.46e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP19A1—uterine cancer	1.22e-06	7.46e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—MTHFR—uterine cancer	1.22e-06	7.43e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—MTHFR—uterine cancer	1.15e-06	7.02e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NRAS—uterine cancer	1.14e-06	6.99e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—RRM2—uterine cancer	1.12e-06	6.83e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—uterine cancer	1.12e-06	6.82e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—DCN—uterine cancer	1.09e-06	6.63e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTEN—uterine cancer	1.07e-06	6.56e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTEN—uterine cancer	1.04e-06	6.34e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—EP300—uterine cancer	1.02e-06	6.25e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.02e-06	6.25e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.01e-06	6.19e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CA—uterine cancer	1.01e-06	6.16e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—EP300—uterine cancer	9.91e-07	6.05e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KRAS—uterine cancer	9.85e-07	6.01e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP19A1—uterine cancer	9.76e-07	5.96e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—STK11—uterine cancer	9.76e-07	5.96e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKR1C3—uterine cancer	9.67e-07	5.9e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTEN—uterine cancer	9.45e-07	5.77e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTEN—uterine cancer	9.35e-07	5.71e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—MTHFR—uterine cancer	9.19e-07	5.61e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.16e-07	5.59e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CA—uterine cancer	9.05e-07	5.52e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—EP300—uterine cancer	9.01e-07	5.5e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—EP300—uterine cancer	8.92e-07	5.45e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.74e-07	5.33e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—uterine cancer	8.37e-07	5.11e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—uterine cancer	8.24e-07	5.03e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CA—uterine cancer	7.58e-07	4.63e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—STK11—uterine cancer	7.53e-07	4.6e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP19A1—uterine cancer	7.53e-07	4.6e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—uterine cancer	7.39e-07	4.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MTHFR—uterine cancer	7.33e-07	4.48e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CA—uterine cancer	7.33e-07	4.47e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTEN—uterine cancer	6.77e-07	4.13e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CA—uterine cancer	6.67e-07	4.07e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CA—uterine cancer	6.6e-07	4.03e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.46e-07	3.95e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—EP300—uterine cancer	6.46e-07	3.94e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTEN—uterine cancer	6.4e-07	3.91e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—uterine cancer	6.19e-07	3.78e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—EP300—uterine cancer	6.1e-07	3.73e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—uterine cancer	5.99e-07	3.66e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MTHFR—uterine cancer	5.66e-07	3.46e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—uterine cancer	5.45e-07	3.33e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—uterine cancer	5.39e-07	3.29e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTEN—uterine cancer	5.11e-07	3.12e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—EP300—uterine cancer	4.87e-07	2.98e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CA—uterine cancer	4.78e-07	2.92e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CA—uterine cancer	4.51e-07	2.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTEN—uterine cancer	4.08e-07	2.49e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—uterine cancer	3.9e-07	2.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—EP300—uterine cancer	3.89e-07	2.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—uterine cancer	3.69e-07	2.25e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CA—uterine cancer	3.6e-07	2.2e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTEN—uterine cancer	3.15e-07	1.92e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—EP300—uterine cancer	3e-07	1.83e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—uterine cancer	2.94e-07	1.8e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.88e-07	1.76e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—uterine cancer	2.35e-07	1.44e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.22e-07	1.36e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—uterine cancer	1.81e-07	1.11e-05	CbGpPWpGaD
